What is McCulley Allergy?
Based in Memphis, Tennessee, McCulley Allergy Sinus and Asthma Center operates as a comprehensive clinical provider dedicated to the diagnosis and management of complex respiratory and immune-related conditions. By maintaining a network of six strategic locations, the company has established a dominant footprint in regional patient care. Their service portfolio spans environmental allergy mitigation, pediatric and adult asthma management, and advanced treatment for food allergies and immune deficiencies. The firm distinguishes itself through a commitment to high-accessibility healthcare, offering same-day or same-week appointments to ensure rapid intervention for patients suffering from chronic or acute allergic reactions.
How much funding has McCulley Allergy raised?
McCulley Allergy has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in McCulley Allergy
PPP
Public-Private Partnership
What's next for McCulley Allergy?
The infusion of capital from this late-stage funding round is expected to catalyze the next phase of McCulley Allergy's growth strategy. Management is likely to prioritize the expansion of its clinical infrastructure, potentially increasing the number of service centers to capture a larger share of the regional market. Furthermore, the investment provides the necessary liquidity to integrate state-of-the-art diagnostic technologies, thereby enhancing patient outcomes and operational efficiency. As the firm transitions into this growth phase, the focus will remain on maintaining high patient satisfaction scores while scaling its specialized medical offerings to meet the rising demand for comprehensive immunology services.
See full McCulley Allergy company page
